Stereotaxis, Inc. (STXS) Financials

STXS Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 44.5 million 20.2 million
2023-06-30 48.3 million 21.3 million
2023-03-31 50.7 million 21.4 million
2022-12-31 53.4 million 21.5 million

STXS Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -977000 2.7 million
2023-06-30 -2.9 million 2.7 million
2023-03-31 -3.2 million 2.7 million
2022-12-31 -2.9 million 2.7 million

STXS Net Income

No data available :(

STXS Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 22.1 million - 5.6 million
2023-06-30 22.9 million - 5.7 million
2023-03-31 25.7 million - 5.8 million
2022-12-31 28.4 million - 5.9 million

STXS Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 82.5 million
2023-06-30 81.0 million
2023-03-31 76.5 million
2022-12-31 76.3 million

STXS Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 10000 2.7 million 3.9 million 3.1 million
2023-06-30 7000 2.6 million 3.5 million 3.3 million
2023-03-31 349000 2.7 million 3.6 million 3.1 million
2022-12-31 369000 2.4 million 3.4 million 3.0 million

STXS Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 7.8 million 3.7 million
2023-06-30 7.9 million 3.7 million
2023-03-31 6.5 million 2.7 million
2022-12-31 7.3 million 3.0 million

STXS

Price: $2.30

52 week price:
1.33
3.29

Payout Ratio Range:
-57303.37%
-15887.85%

Earnings Per Share: -0.27 USD

P/E Ratio: -8.04

Exchange: ASE

Sector: Healthcare

Industry: Medical Instruments & Supplies

Volume: 50343

Ebitda: -5.0 million

Market Capitalization: 239.0 million

Links: